HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NMK-TD-100

a microtubule modulator; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Thiadiazoles: 99
        NMK-TD-100: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - NMK-TD-100: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Thiadiazoles: 99
      - NMK-TD-100: 1

Experts

1.	Bhattacharya, Surela: 1 article (01/2013)
2.	Chakrabarti, Gopal: 1 article (01/2013)
3.	Ganguli, Arnab: 1 article (01/2013)
4.	Kumar, Dalip: 1 article (01/2013)
5.	Kumar, N Maruthi: 1 article (01/2013)
6.	Tantak, Mukund P: 1 article (01/2013)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2013 - "However, the cytotoxicity of NMK-TD-100 towards human peripheral blood mononuclear cells (PBMC) was lower compared to that in cancer cells. " 01/01/2013 - "We screened for the growth inhibitory effect of synthetic 5-(3-indolyl)-2-substituted-1,3,4-thiadiazoles on cancer cells and identified NMK-TD-100, as the most potent agent. " 01/01/2013 - "In further study, we examined the mode of interaction of NMK-TD-100 with tubulin and unraveled the cellular mechanism responsible for its anti-tumor activity. "
2.	Carcinoma (Carcinomatosis) 01/01/2013 - "Cell viability experiments using human cervical carcinoma cell line (HeLa cells) indicated that the IC50 value was 1.42±0.11 µM for NMK-TD-100 for 48 h treatment. "

Related Drugs and Biologics

1.	Tubulin